MAFA
HALO icon

MJT & Associates Financial Advisory’s Halozyme HALO Stock Holding History

MJT & Associates Financial Advisory’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.53K Hold
41
– – ﹤0.01% 284
2026
Q2 		$3.21K Buy
41
+3
+8% +$205 ﹤0.01% 337
2026
Q1 		$2.46K Hold
38
– – ﹤0.01% 357
2025
Q4 		$2.56K Hold
38
– – ﹤0.01% 367
2025
Q3 		$2.79K Buy
+38
New +$2.52K ﹤0.01% 367

Other funds holding HALO

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $480M AUM 43.68% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MAG
MRA Advisory Group Parsippany, New Jersey $267M AUM 19.2% 1-Year Est. Return
CFO
Collective Family Office York, Pennsylvania $484M AUM 13.93% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
WWM
Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return

MJT & Associates Financial Advisory's HALO Position: Q3 2026 in Review

MJT & Associates Financial Advisory held its Halozyme (HALO) position steady in Q3 2026 at 41 shares worth $4.53K. The position accounts for ﹤0.01% of the portfolio, ranked #284.

MJT & Associates Financial Advisory first reported a position in HALO in Q3 2025 and has held it in 5 quarters since. 31 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • MJT & Associates Financial Advisory held 41 shares of Halozyme worth $4.53K as of Q3 2026.
  • MJT & Associates Financial Advisory left its Halozyme share count unchanged in Q3 2026.
  • Halozyme made up ﹤0.01% of MJT & Associates Financial Advisory's portfolio in Q3 2026, its #284 holding.
  • MJT & Associates Financial Advisory first reported a position in Halozyme in Q3 2025 and has held it in 5 quarters since.
  • 31 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on MJT & Associates Financial Advisory's 13F filing for Q3 2026, filed 7 Oct 2026.